People living with obesity have an increased risk of CVD, but to date, there are no approved weight management medications proven to deliver effective weight management while also reducing the risk of heart attack, stroke or cardiovascular death, Martin Holst Lange, Novo Nordisks executive vice president for development, said in a prepared statement
Related Reading Glp 1 For High Cholesterol Glp 1 For High Blood Pressure Can You Get Your Glp 1 Tested Maximus Glp 1 Pricing and availability current as of June 2026
While the chemicals are not inherently harmful, lack of regulation in their quantity usually results in adverse reactions
The SURPASS clinical trial program demonstrated that tirzepatide at its highest dose (15 mg weekly) produced average weight loss of 20-25% of body weight, significantly exceeding the results seen with GLP-1 only agonists
The result is that the exact same medication, from the same manufacturing facility, distributed through authorized channels, costs dramatically less simply because of where it is sold
Propionic acidemia: identification of twenty-four novel mutations in Europe and North America
